Patent · US Active

Dosage form for hormonal contraception

US8580771B2 · kind B2 · utility

0Cited by

5References

13Claims

0Family size

Assignee

RICHTER GEDEON NYRT. · HU

Inventors

Georg Schramm · Stolberg, DE
Eric-Paul Paques · Marburg, DE

Key dates

Filing date	Oct 6, 2005
Grant date	Nov 12, 2013
Priority date	—
Expiry date	Jul 5, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A dosage form for hormonal contraception containing a given number of hormone-containing daily units and a given number of hormone-free daily units for daily, oral administration, where the hormone-containing daily units each contain at most the minimum effective daily amount of folic acid for women and the hormone-free daily units contain at least a multiple of this amount up to the maximum permissible amount of folic acid for women.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.